TickerFacts.

YD Bio Ltd (YDES): Operating Income

Annual figures by period end, from SEC filings.

-$5.27M
Year ended 2025-12-31
2023-12-31: -$9.8K2024-12-31: -$1.46M2025-12-31: -$5.27M-$5.27M
2023-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$5.27Mn/m2026-04-30, From 2025-01-01
2024-12-31-$1.46Mn/m2026-04-30, From 2024-01-01
2023-12-31-$9.8Kn/a2026-04-30, From 2023-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
YD Bio Ltd (YDES)2025-12-31-$5.27Mn/m
Sera Prognostics, Inc. (SERA)2025-12-31-$36.50Mn/m
Aclarion, Inc. (ACON)2025-12-31-$7.05Mn/m
BioNexus Gene Lab Corp (BGLC)2025-12-31-$2.97Mn/m
American Shared Hospital Services (AMS)2025-12-31-$3.59Mn/m
CapForce Inc. (CFOR)2025-12-31$24.03Mn/m
Exagen Inc. (XGN)2025-12-31-$14.07Mn/m
Personalis, Inc. (PSNL)2025-12-31-$88.06Mn/m
Biodesix Inc (BDSX)2025-12-31-$27.87Mn/m

Compare YDES, SERA, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗